Introduction
If your patent application includes nucleotide or amino acid sequences, you will likely need a sequence listing — a standardized, machine-readable document required by patent offices worldwide. Missing or non-compliant listings can delay prosecution, jeopardize filing dates, or create validity risks. Yet many applicants underestimate the cost and complexity involved. Sequence listing preparation can range from under $200 for a simple filing to $50,000+ for large genomic applications. This guide explains what sequence listing preparation involves, what drives pricing, and what you should realistically budget under the current ST.26 standard.
What Does Sequence Listing Preparation Involve?
A compliant ST.26 listing typically requires:
- Extracting and verifying sequences
- Assigning accurate SEQ ID NOs
- Preparing ST.26 XML files
- Adding biological feature annotations
- Drafting free-text qualifiers
- Running WIPO Sequence validation checks
- Cross-checking references against the specification and claims
This is part bioinformatics, part molecular biology, and part patent compliance work.
Main Factors That Affect Cost
1. Number of Sequences
The biggest pricing factor. More sequences mean more formatting, validation, and review work.
2. Sequence Complexity
Simple peptides are inexpensive. Antibodies, CRISPR constructs, fusion proteins, and gene therapy vectors require extensive annotation and cost more.
3. Source Data Quality
Clean FASTA files reduce cost. Extracting sequences from PDFs, spreadsheets, or draft specifications increases preparation time and error risk.
4. Annotation Requirements
ST.26 requires structured annotations for many sequence types, especially biologics and engineered constructs.
5. Turnaround Time
Rush filings typically increase fees by 30%–75%.
6. ST.25 Conversion
Older applications often require ST.25-to-ST.26 conversion, which is billed separately.
Typical Sequence Listing Costs
Specialized Sequence Listing Providers
| Sequence Count | Typical Cost |
| 1–10 | $150 – $500 |
| 11–50 | $450 – $1,800 |
| 51–150 | $1,500 – $4,500 |
| 151–500 | $4,000 – $10,000 |
| 500+ | $10,000 – $40,000+ |
Rush delivery: +30%–75%
Patent Law Firms
Law firms usually charge higher rates because they include legal review and prosecution coordination.
| Sequence Count | Typical Cost |
| 1–10 | $400 – $1,200 |
| 11–50 | $900 – $3,500 |
| 51–150 | $3,000 – $8,000 |
| 151–500 | $7,000 – $20,000 |
Freelance Specialists
Independent ST.26 specialists may charge lower rates, but quality varies significantly.
| Sequence Count | Typical Cost |
| 1–10 | $100 – $400 |
| 11–50 | $300 – $1,200 |
| 51–150 | $900 – $3,000 |
Always verify ST.26 expertise and validation experience before hiring.
ST.26 Conversion Costs
Converting older ST.25 listings to ST.26 usually costs:
| Complexity | Typical Cost |
| Simple | $250 – $700 |
| Moderate | $700 – $2,000 |
| Complex | $2,000 – $5,000+ |
The more annotations required, the higher the cost.
Large-Scale Genomic Filings
Applications involving NGS panels, metagenomics, or large genomic datasets may include thousands of sequences.
At this scale:
- Automated pipelines are typically required
- Manual QC remains essential
- Coordination with bioinformatics teams is common
Typical costs: $20,000 – $100,000+
How to Reduce Sequence Listing Costs
- Provide Clean FASTA Files
- Well-organized sequence data dramatically reduces preparation time and error risk.
- Finalize Sequences Early
- Late-stage additions or deletions create expensive rework.
- Avoid Rush Filings
- Build sequence listing preparation into your prosecution timeline early.
- Reuse Existing Listings
- Continuation and divisional applications can often reuse parent listings with modifications.
- Use Experienced Providers
- Cheap, poorly prepared listings often become expensive during prosecution.
Example Budget Scenarios
| Scenario | Estimated Cost |
| Startup provisional with 6 peptide sequences | $150 – $400 |
| University PCT with 32 sequences | $900 – $2,500 |
| Antibody patent application | $1,200 – $3,500 |
| Biologics portfolio with 150 sequences | $5,000 – $12,000 |
| Genomics application with 2,400 sequences | $25,000 – $60,000 |
| ST.25 to ST.26 conversion (55 sequences) | $800 – $2,000 |
Way Forward
Sequence listing preparation is now a highly technical ST.26 compliance exercise rather than a simple formatting task. Costs are driven primarily by sequence count, annotation complexity, source data quality, and turnaround requirements.
For most filings, professional preparation costs range from $200 to $5,000, while large genomic applications can cost substantially more.
The best way to control costs is simple:
- provide clean sequence data,
- plan ahead,
- avoid rush filings,
- and work with experienced ST.26 specialists.
A properly prepared sequence listing is not just an administrative requirement — it is a critical component of a defensible life sciences patent strategy.